Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Concord Biotech Limited
No Price
Closing Price XBOM 29.04.2026:
1.144,70 INR
29.04.2026 06:10
Current Prices from Concord Biotech Limited
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NSE
CONCORDBIO.NS
INR
29.04.2026 06:10
1.138,90 INR
66,90 INR
+6,24 %
MSE
CONCORDBIO.BO
INR
29.04.2026 05:55
1.144,70 INR
72,70 INR
+6,78 %
Share Float & Liquidity
Free Float25,62 %
Shares Float26,8 M
Shares Outstanding104,62 M
Company Profile for Concord Biotech Limited Share
Concord Biotech Limited, a biopharma company, engages in the research and development, manufacturing, marketing, and sale of pharmaceutical products in India and internationally. It provides fermentation based active pharmaceutical ingredients in immunosuppressants, anti-bacterial, oncology, antifungal, and other therapeutic areas. The company also offers tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, and pimecrolimus for immunosuppressants therapeutic segment; temsirolimus, everolimus, romidepsin, mitomycin, midostaurin, and dactinomycin for oncology therapeutic segment; mupirocin, mupirocin calcium, vancomycin hydrochloride, and teicoplanin for anti-bacterial applications; anidulafungin, caspofungi, and micafungin sodium for anti-fungal therapeutic segment; and lovastatin and pravastatin sodium for other applications. In addition, it provides contract research and manufacturing services in the areas of fermentation and semi-synthesis products. Concord Biotech Limited was incorporated in 1984 and is based in Ahmedabad, India.
